Kalehua Capital Management »

Galecto shares owned by Kalehua Capital Management

Quarter-by-quarter ownership of Galecto (DMRA) shares owned by Kalehua Capital Management from 13F filings

Historical chart of Kalehua Capital Management investment in Galecto

Tip: Access up to 7 years of quarterly data

All positions including Galecto held by Kalehua Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galecto by Kalehua Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.6M 139k 25.90

More positions owned by Kalehua Capital Management

Alpha Architect 1-3 Month Box ETF Alpha Arch 1-3 (BOXX)
X4 Pharmaceuticals Com New (XFOR)
Surrozen Com New (SRZN)
Veradermics Common Stock
Relay Therapeutics (RLAY)
Sionna Therapeutics (SION)
Aclaris Therapeutics (ACRS)
Inhibikase Therapeutics Com New (IKT)
Oruka Therapeutics (ORKA)
Pharvaris N V (PHVS)
Uniqure NV SHS (QURE)
Septerna (SEPN)
Compass Pathways Sponsored Ads (CMPS)
Athira Pharma (LONA)
Damora Therapeutics Com New (DMRA)

View all positions for Kalehua Capital Management

Top funds holding Galecto

Fairmount Funds Management
VR Adviser
RA Capital Management
Henderson Group
Viking Global Investors
Remedium Capital Partners
Commodore Capital
Cormorant Asset Management
Balyasny Asset Management
AH Capital Management
Perceptive Advisors
Point72 Asset Management
Braidwell
Vestal Point Capital
Blackstone Group

View all funds holding Galecto